Cell cycle arrest and induction of apoptosis by β galactoside binding protein (̄GBP) in human mammary cancer cells. A potential new approach to cancer control

European Journal of Cancer

Volumn 35, Issue 6, 1999, Pages 978-983

  Wells, V ^a   Davies, D ^b   Mallucci, L ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

GBP; Apoptosis; Mammary cancer cells

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; GALAPTIN; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CONTROL; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; FEMALE; GALECTINS; HEMAGGLUTININS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0033153039     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00020-9     Document Type: Article

References (28)

1. Wells V., Mallucci L. Identification of an autocrine negative growth factor: mouse β-galactoside-binding protein is a cytostatic factor and cell growth regulator. Cell. 64:1991;91-97.
2. Wells V., Mallucci L. Molecular expression of the negative growth-factor murine β-galactoside binding-protein (mGBP). Biochim. Biophys. Acta. 1121:1992;239-244.
3. Allione A., Wells V., Forni G., Mallucci L., Novelli F. β galactoside binding protein (βGBP) alters the cell cycle, up-regulates expression of the α and β chains of the IFN-γ receptor and triggers IFN-γ-mediated apoptosis of activated human T lymphocytes. J. Immun. 161:1998;2114-2119.
4. Novelli F., Allione A., Wells V., Forni G., Mallucci L. Negative cell cycle control of human T cells by β-galactoside binding protein (βGBP). Induction of programmed cell death in leukaemic cells. J. Cell. Physiol. 178:1999;102-108.
5. Blaser C., Kaufmann M., Müller C.et al. β galactoside binding protein secreted by activated T cells inhibits antigen induced proliferation of T cells. Eur. J. Immun. 28:1998;2311-2319.
6. Lasfargues E.Y., Ozzello L. Cultivation of human breast carcinomas. J. Natl. Cancer Inst. 21:1958;1131-1147.
7. Keydar J., Chen J., Kary S.et al. Establishment and characterisation of a cell line of human breast carcinoma origin. Eur. J. Cancer. 15:1979;659-670.
8. Bartek J., Bartkova J., Lalai E-N., Brezina V., Taylor-Papadimitriou J. Selective immortalization of phenotypically distinct epithelial cell type by micro-injection of SV40 DNA into cultured human milk cells. Int. J. Cancer. 45:1990;1105-1112.
9. Bartek J., Bartkova J., Kyprianou N.et al. Efficient immortalisation of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumour antigen with a recombinant retrovirus. Proc. Natl. Acad. Sci. USA. 88:1991;3520-3524.
10. Cowley S.J., Leevers S., Hancock D., Marshall C.L. Activation of MAP kinase is both necessary and sufficient for the progression of PK12 through S phase. Cell. 21:1995;31-39.
11. Imai Y., Leung C.K., Friesen H.G., Shiu R.P. Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long term tissue culture. Cancer Res. 42:1982;4394-4398.
12. Chiariotti L., Wells V., Bruni C.B., Mallucci L. Structure and expression of the negative growth factor mouse β-galactoside binding protein gene. Biochim. Biophys. Acta. 1089:1991;54-60.
13. Baldini A., Gress T., Patel K.et al. Mapping on human and mouse chromosomes of the gene for the β-galactoside binding protein, an autocrine-negative growth factor. Genomics. 15:1993;216-218.
14. Aurias A., Rimbaut C., Buffe D., Zucker J.M., Mazabraud A. Translocation involving chromosome 22 in Ewing's sarcoma. A cytogenetic study of four fresh tumours. Cancer Genet. Cytogenet. 12:1984;21-25.
15. Turc Carel C., Dal Cin P., Rao U., Karakousis C., Sandberg A.A. Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcoma. Cancer Genet. Cytogenet. 30:1988;145-150.
16. Bridge J.A., Borek D.A., Neff J.R., Huntrakoon M. Chromosomal abnormalities in clear cell sarcoma. Implication for histogenesis. Am. J. Clin. Pathol. 93:1990;26-31.
17. Rey J.A., Bello M.J., de Campos J.M.et al. Abnormalities of chromosome 22 in human brain tumours determined by combined cytogenetic and molecular genetic approaches. Cancer Genet. Cytogenet. 66:1993;1-10.
18. Lu P.J., Lu Q.L., Rughetti A. Taylor-Papadimitriou J. Bcl 2 overexpression inhibits cell death and promotes the morphogenesis but not tumorigenesis of human mammary epithelial cells. J. Cell. Biol. 129:1995;1363-1378.
19. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. p53-dependent apoptosis modulates the cytoxicity of anticancer agents. Cell. 74:1993;957-967.
20. Fisher D.E. Apoptosis in cancer therapy: crossing the threshold. Cell. 78:1993;539-542.
21. Askew D.S., Ashmun R.A., Simmons B.C., Cleveland J.L. Constitutive c-myc expression in an IL3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. 6:1991;1915-1922.
22. Symonds H., Krall L., Remington L.et al. p53-dependent apoptosis suppresses tumour growth and progression in vivo. Cell. 78:1994;703-711.
23. Karunagaran D., Tzahar E., Beerli R.G.et al. ErbB.2 is a common auxiliary subunit of NDF and EGF: implication for breast cancer. EMBO J. 15:1996;254-264.
24. Taylor-Papadimitriou J, Bedichersky F, D'Sousa B, Burchel J. Human models of breast cancer. In Lemoine NR, Wright NA, eds. Cancer Survey: The Molecular Pathology of Cancer, Vol. 16. Cold Spring Harbor Laboratory Press, 1993, 59-78.
25. Mallucci L., Wells V. Negative control of cell proliferation. Growth arrest versus apoptosis. Role of βGBP. J. Theor. Med. 1:1998;169-173.
26. Krek W., Xu G., Livingston D.M. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell. 83:1995;1149-1158.
27. De Gregori J., Leone G., Miron A., Jakoi L., Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci, USA. 94:1997;7245-7250.
28. Bargou R.C., Wagener C., Bommert K.et al. Blocking of transcription factor E2F/DP by dominant negative mutants in a normal breast epithelial line efficiently inhibits apoptosis and induces tumor growth in SCID mice. J. Exp. Med. 183:1996;1205-1213.